Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.380
+0.030 (2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aytu BioPharma Employees
Aytu BioPharma had 102 employees as of June 30, 2024. The number of employees decreased by 48 or -32.00% compared to the previous year.
Employees
102
Change (1Y)
-48
Growth (1Y)
-32.00%
Revenue / Employee
$781,951
Profits / Employee
-$61,275
Market Cap
8.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
RedHill Biopharma | 53 |
Viracta Therapeutics | 40 |
Dominari Holdings | 28 |
Purple Biotech | 20 |
BioCardia | 20 |
Virax Biolabs Group | 17 |
QT Imaging Holdings | 14 |
AYTU News
- 18 days ago - Aytu BioPharma Disclosure Notification - Accesswire
- 4 weeks ago - Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) - Accesswire
- 5 weeks ago - Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results - Accesswire
- 6 weeks ago - Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 - Accesswire
- 2 months ago - Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit - Accesswire
- 2 months ago - Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada - Accesswire
- 3 months ago - Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript - Seeking Alpha